What is the address of Dr. Charlotte Van Langenhove, Radiologie?

The registered office of Dr. Charlotte Van Langenhove, Radiologie is located at Molendreef(B) 36, 9290 Berlare.

Is Dr. Charlotte Van Langenhove, Radiologie still active?

Yes. According to the CBE (29 September 2026) Dr. Charlotte Van Langenhove, Radiologie is active, legal situation “Normale toestand”, started on 23 December 2021.

Is Dr. Charlotte Van Langenhove, Radiologie registered on Peppol?

Yes, Dr. Charlotte Van Langenhove, Radiologie is registered on the Peppol network with ID 0208:0779288397.

What is the enterprise number of Dr. Charlotte Van Langenhove, Radiologie?

The enterprise number of Dr. Charlotte Van Langenhove, Radiologie is BE0779288397.

When was Dr. Charlotte Van Langenhove, Radiologie founded?

Dr. Charlotte Van Langenhove, Radiologie was founded on 23 December 2021.

Who are the directors of Dr. Charlotte Van Langenhove, Radiologie?

According to the 2025 annual accounts, the directors of Dr. Charlotte Van Langenhove, Radiologie are: Charlotte Van Langenhove.

Is Dr. Charlotte Van Langenhove, Radiologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 23 December 2021; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Charlotte Van Langenhove, Radiologie make in 2025?

Dr. Charlotte Van Langenhove, Radiologie posted a profit after taxes of € 371,726 in financial year 2025.

What is the revenue of Dr. Charlotte Van Langenhove, Radiologie?

As a small company, Dr. Charlotte Van Langenhove, Radiologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 495,759.

Dr. Charlotte Van Langenhove, Radiologie (Private Limited)

Dossier Dr. Charlotte Van Langenhove, Radiologie, printed on 29 September 2026 from databakkes.be/en/0779288397/dr-charlotte-van-langenhove-radiologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Charlotte Van Langenhove, Radiologie from Berlare, company number BE0779288397, closed financial year 2025 with a result of € 371,726 after tax. For that financial year Dr. Charlotte Van Langenhove, Radiologie recorded a gross margin of € 495,759 and equity of € 595,362. Compared with financial year 2024, the result moved from € 205,920 to € 371,726. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.

What it is worth Growing

€ 595,362

▲ 47% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 371,726

▲ 81% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 340,118

▼ 12% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 182,242 paid out

49 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 16,938

▲ 53% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 9,771

▲ 88% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 38,039 Gross margin 2022: € 38,039 First fiscal year in the series	€ 249,188 Gross margin 2023: € 249,188 ▲ € 211,148 vs 2022 (€ 38,039) Favourable step	€ 270,626 Gross margin 2024: € 270,626 ▲ 9% vs 2023 (€ 249,188) Favourable step	€ 495,759 Gross margin 2025: € 495,759 ▲ 83% vs 2024 (€ 270,626) Favourable step	▲ 83%
Profit after taxes	€ 25,625 Profit after taxes 2022: € 25,625 First fiscal year in the series	€ 171,333 Profit after taxes 2023: € 171,333 ▲ € 145,709 vs 2022 (€ 25,625) Favourable step	€ 205,920 Profit after taxes 2024: € 205,920 ▲ 20% vs 2023 (€ 171,333) Favourable step	€ 371,726 Profit after taxes 2025: € 371,726 ▲ 81% vs 2024 (€ 205,920) Favourable step	▲ 81%
Equity	€ 28,625 Equity 2022: € 28,625 First fiscal year in the series	€ 199,958 Equity 2023: € 199,958 ▲ € 171,333 vs 2022 (€ 28,625) Favourable step	€ 405,878 Equity 2024: € 405,878 ▲ 103% vs 2023 (€ 199,958) Favourable step	€ 595,362 Equity 2025: € 595,362 ▲ 47% vs 2024 (€ 405,878) Favourable step	▲ 47%
Total debts	€ 16,342 Total debts 2022: € 16,342 First fiscal year in the series	€ 81,555 Total debts 2023: € 81,555 ▲ € 65,213 vs 2022 (€ 16,342) Unfavourable step	€ 68,448 Total debts 2024: € 68,448 ▼ 16% vs 2023 (€ 81,555) Favourable step	€ 11,117 Total debts 2025: € 11,117 ▼ 84% vs 2024 (€ 68,448) Favourable step	▼ 84%
Cash	€ 27,817 Cash 2022: € 27,817 First fiscal year in the series	€ 154,045 Cash 2023: € 154,045 ▲ € 126,228 vs 2022 (€ 27,817) Favourable step	€ 388,425 Cash 2024: € 388,425 ▲ 152% vs 2023 (€ 154,045) Favourable step	€ 340,118 Cash 2025: € 340,118 ▼ 12% vs 2024 (€ 388,425) Unfavourable step	▼ 12%
Retained profit	€ 25,625 Retained profit 2022: € 25,625 First fiscal year in the series	€ 196,958 Retained profit 2023: € 196,958 ▲ € 171,333 vs 2022 (€ 25,625) Favourable step	€ 402,878 Retained profit 2024: € 402,878 ▲ 105% vs 2023 (€ 196,958) Favourable step	€ 592,362 Retained profit 2025: € 592,362 ▲ 47% vs 2024 (€ 402,878) Favourable step	▲ 47%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 182,242 Dividend 2025: € 182,242 Unchanged (€ 0) Unchanged
Balance sheet total	€ 44,967 Balance sheet total 2022: € 44,967 First fiscal year in the series	€ 281,513 Balance sheet total 2023: € 281,513 ▲ € 236,546 vs 2022 (€ 44,967) Unchanged	€ 474,326 Balance sheet total 2024: € 474,326 ▲ 68% vs 2023 (€ 281,513) Unchanged	€ 606,479 Balance sheet total 2025: € 606,479 ▲ 28% vs 2024 (€ 474,326) Unchanged	▲ 28%

Key figures of Dr. Charlotte Van Langenhove, Radiologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Charlotte Van Langenhove, Radiologie?

What happened at Dr. Charlotte Van Langenhove, Radiologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 31, 2026 New annual accounts for financial year 2025: profit of € 371,726 (▲ 81% vs 2024). Source: NBB ↗
Dec 23, 2021 New establishment in Berlare. KBO
2021 Charlotte Van Langenhove became a director. NBB
Dec 23, 2021 Start of the company according to the CBE. KBO

In short

From € 25,625 profit in 2022 to € 371,726 profit in 2025.

Paid € 268,541 in corporate taxes since 2022.

Best year ever: 2025, with € 371,726 profit.

Paid out € 182,242 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Charlotte Van Langenhove, Radiologie? We notify you, reason included.

Follow Dr. Charlotte Van Langenhove, Radiologie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Charlotte Van Langenhove

Dr. Charlotte Van Langenhove, Radiologie

Behind Dr. Charlotte Van Langenhove, Radiologie is Charlotte Van Langenhove.

See the full network in the app

Directors

According to the 2025 annual accounts

Charlotte Van Langenhove

Director

since 2021

Establishments

Establishment units

Physical locations of this company

Registered office

Molendreef(B) 36

9290 Berlare

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Thomas Van der Borght

€ 25,828 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0779.288.397
VAT number: BE 0779.288.397
Registered office: Molendreef(B) 36, 9290 Berlare
Names & denominations: Dr. Charlotte Van Langenhove, Radiologie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 23 December 2021
Peppol: Active · Active since 10 Sept 2025

View on CBE Public ↗ Annual accounts (NBB) ↗